In addition, A151 was also able to inhibit the production of IFN‐I in TREX1‐deficient cells, raising the possibility that A151 may be used for the treatment of dsDNA‐mediated autoimmune diseases.313. This evidence concerns the gene TREX1 and autoimmune disease.